LncRNA CCAT2 expression at diagnosis predicts imatinib response in chronic phase chronic myeloid leukemia patients
Long noncoding RNAs (lncRNAs) are identified as key players in the initiation, development, and prognosis of chronic myeloid leukemia (CML). Some lncRNAs are expected to serve as diagnostic biomarkers, predictors of clinical outcomes and therapeutic targets. We aimed to examine the expression of lnc...
Saved in:
Published in | Leukemia research Vol. 116; p. 106838 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
England
Elsevier Ltd
01.05.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Long noncoding RNAs (lncRNAs) are identified as key players in the initiation, development, and prognosis of chronic myeloid leukemia (CML). Some lncRNAs are expected to serve as diagnostic biomarkers, predictors of clinical outcomes and therapeutic targets. We aimed to examine the expression of lncRNA colon cancer-associated transcript 2 (CCAT2) in CML patients, as well as to correlate CCAT2 expression with response to imatinib therapy. 43 newly diagnosed patients with chronic phase CML were included, and 30 healthy persons were selected as controls. Real-time reverse transcription PCR was performed to analyze the expression of CCAT2 in peripheral blood mononuclear cells. Our results reported for the first time the upregulated expression of CCAT2 in CML patients as compared with controls (P < 0.001). We demonstrated significant association between CCAT2 expression and therapy response at 3 months, and at 6 months (P = 0.004, and P = 0.005; respectively). Moreover, CCAT2 expression was significantly associated with spleen size (P = 0.006) and EUTOS sore (P = 0.030). LncRNA CCAT2 is highly expressed in the peripheral blood of CML patients, and the enhanced expression at diagnosis is linked to imatinib resistance. CCAT2 is expected to become a reliable molecular marker for predicting imatinib response in chronic phase CML patients.
•LncRNA CCAT2 is upregulated in peripheral blood mononuclear cells of CML patients.•Increased expression of CCAT2 can predict imatinib resistance in CP CML patients.•Relative CCAT2 expression levels are closely associated with EUTOS sore. |
---|---|
AbstractList | Long noncoding RNAs (lncRNAs) are identified as key players in the initiation, development, and prognosis of chronic myeloid leukemia (CML). Some lncRNAs are expected to serve as diagnostic biomarkers, predictors of clinical outcomes and therapeutic targets. We aimed to examine the expression of lncRNA colon cancer-associated transcript 2 (CCAT2) in CML patients, as well as to correlate CCAT2 expression with response to imatinib therapy. 43 newly diagnosed patients with chronic phase CML were included, and 30 healthy persons were selected as controls. Real-time reverse transcription PCR was performed to analyze the expression of CCAT2 in peripheral blood mononuclear cells. Our results reported for the first time the upregulated expression of CCAT2 in CML patients as compared with controls (P < 0.001). We demonstrated significant association between CCAT2 expression and therapy response at 3 months, and at 6 months (P = 0.004, and P = 0.005; respectively). Moreover, CCAT2 expression was significantly associated with spleen size (P = 0.006) and EUTOS sore (P = 0.030). LncRNA CCAT2 is highly expressed in the peripheral blood of CML patients, and the enhanced expression at diagnosis is linked to imatinib resistance. CCAT2 is expected to become a reliable molecular marker for predicting imatinib response in chronic phase CML patients.
•LncRNA CCAT2 is upregulated in peripheral blood mononuclear cells of CML patients.•Increased expression of CCAT2 can predict imatinib resistance in CP CML patients.•Relative CCAT2 expression levels are closely associated with EUTOS sore. Long noncoding RNAs (lncRNAs) are identified as key players in the initiation, development, and prognosis of chronic myeloid leukemia (CML). Some lncRNAs are expected to serve as diagnostic biomarkers, predictors of clinical outcomes and therapeutic targets. We aimed to examine the expression of lncRNA colon cancer-associated transcript 2 (CCAT2) in CML patients, as well as to correlate CCAT2 expression with response to imatinib therapy. 43 newly diagnosed patients with chronic phase CML were included, and 30 healthy persons were selected as controls. Real-time reverse transcription PCR was performed to analyze the expression of CCAT2 in peripheral blood mononuclear cells. Our results reported for the first time the upregulated expression of CCAT2 in CML patients as compared with controls (P < 0.001). We demonstrated significant association between CCAT2 expression and therapy response at 3 months, and at 6 months (P = 0.004, and P = 0.005; respectively). Moreover, CCAT2 expression was significantly associated with spleen size (P = 0.006) and EUTOS sore (P = 0.030). LncRNA CCAT2 is highly expressed in the peripheral blood of CML patients, and the enhanced expression at diagnosis is linked to imatinib resistance. CCAT2 is expected to become a reliable molecular marker for predicting imatinib response in chronic phase CML patients. |
ArticleNumber | 106838 |
Author | Shehata, Amira M.F. Muharram, Nashwa M. Eldin, Samar M. Kamal Gohar, Suzy F. |
Author_xml | – sequence: 1 givenname: Amira M.F. surname: Shehata fullname: Shehata, Amira M.F. email: amira.mohammed.fouad@med.menofia.edu.eg, amirafoad1@yahoo.com organization: Clinical Pathology Department, Faculty of Medicine, Menoufia University, Menoufia 32511, Egypt – sequence: 2 givenname: Suzy F. surname: Gohar fullname: Gohar, Suzy F. email: suzygohar@ymail.com, sozy.johar@med.menofia.edu.eg organization: Clinical Oncology Department, Faculty of Medicine, Menoufia University, Menoufia 32511, Egypt – sequence: 3 givenname: Nashwa M. surname: Muharram fullname: Muharram, Nashwa M. email: nashwa.mouharam@med.menofia.edu.eg, ezzelgazzar@yahoo.com organization: Medical Biochemistry and Molecular Biology Department, Faculty of Medicine, Menoufia University, Menoufia 32511, Egypt – sequence: 4 givenname: Samar M. Kamal surname: Eldin fullname: Eldin, Samar M. Kamal email: samar_kamal186@med.menofia.edu.eg organization: Clinical Pathology Department, Faculty of Medicine, Menoufia University, Menoufia 32511, Egypt |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35367722$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkEtPGzEURq2KqiS0PwHkJZsJfow9nhWKIqCVIipVdG157BtwmLEHe1LBv8dRAtuuLF-d7z7OHJ2EGAChc0oWlFB5tV30sHtOkBeMMFZqUnH1Bc2oanglFBcnaEZoLSpGmTxF85y3hBDR0vYbOuWCy6ZhbIbSOtg_90u8Wi0fGIbXsXTMPgZsJuy8eQwx-4xL1Xk7ZewHM_ngO1ywMYYM2Adsn1IM3uLxyZTCx294gz56h_drwuANHksUwpS_o68b02f4cXzP0N_bm4fVz2r9--7XarmuLGvFVHVKOemMcJwxxUEoooSFGljj1AaotBvbdC0jHecdcYJBTZ3hBWXWgJHAz9Dloe-Y4ssO8qQHny30vQkQd1kzWcu2rgknBRUH1KaYc4KNHlM5Nb1pSvRet97qo269160Pukvu4jhi1w3gPlMffgtwfQCgHPrPQ9LZFgm26ExgJ-2i_8-Id749l04 |
CitedBy_id | crossref_primary_10_3390_genes14010131 crossref_primary_10_3390_ijms232012271 crossref_primary_10_3389_frnar_2024_1334464 crossref_primary_10_1002_cam4_6027 crossref_primary_10_1007_s00277_023_05383_3 |
Cites_doi | 10.1038/onc.2014.456 10.1016/j.bbrc.2016.08.120 10.23736/S0026-4806.17.04703-6 10.1177/1010428317711314 10.3390/ijms20246141 10.3748/wjg.v25.i17.2029 10.1186/s13059-018-1523-0 10.4062/biomolther.2016.162 10.18632/oncotarget.8259 10.2147/OTT.S127100 10.1038/ng.3192 10.4084/mjhid.2014.007 10.1186/s40659-017-0149-0 10.1089/dna.2016.3533 10.1186/s13000-016-0499-x 10.3389/fonc.2019.00939 10.1007/s00277-020-04161-9 10.1016/j.gene.2017.01.004 10.1182/asheducation-2009.1.461 10.6004/jnccn.2020.0047 10.1038/nprot.2008.73 10.1155/2017/7243968 10.18632/oncotarget.13242 10.1016/j.biopha.2017.05.030 10.1053/j.gastro.2020.08.018 10.2174/0929867321666140414101939 10.1097/MOH.0000000000000403 10.1016/j.biopha.2019.108758 10.1053/j.gastro.2018.10.054 10.1038/leu.2009.38 10.1101/gr.152942.112 10.1177/2040620712468289 10.1016/j.biopha.2016.12.122 10.1002/jcp.26119 |
ContentType | Journal Article |
Copyright | 2022 Elsevier Ltd Copyright © 2022 Elsevier Ltd. All rights reserved. |
Copyright_xml | – notice: 2022 Elsevier Ltd – notice: Copyright © 2022 Elsevier Ltd. All rights reserved. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1016/j.leukres.2022.106838 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1873-5835 |
EndPage | 106838 |
ExternalDocumentID | 10_1016_j_leukres_2022_106838 35367722 S0145212622000649 |
Genre | Journal Article |
GroupedDBID | --- --K --M .1- .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 29L 4.4 457 4CK 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ 9JM AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AAXUO ABBQC ABEFU ABFNM ABGSF ABJNI ABLVK ABMAC ABMZM ABUDA ABXDB ABYKQ ACDAQ ACGFS ACIUM ACRLP ADBBV ADEZE ADMUD ADUVX AEBSH AEHWI AEKER AENEX AEVXI AFCTW AFFNX AFKWA AFRHN AFTJW AFXIZ AGHFR AGRDE AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJBFU AJOXV AJRQY AJUYK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 DOVZS DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HED HMK HMO HVGLF HZ~ IHE J1W J5H K-O KOM L7B LCYCR M29 M41 MO0 N9A O-L O9- OAUVE OC~ OO- OZT P-8 P-9 PC. Q38 R2- RIG ROL RPZ SAE SCC SDF SDG SEL SES SEW SPCBC SSH SSU SSZ T5K WUQ Z5R ZGI ~G- AKRWK CGR CUY CVF ECM EIF NPM AAXKI AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c295t-b88d6da5d32283e58085ce4e27d8fe16cfc7b920b33b0d52e41da32832caea6e3 |
IEDL.DBID | .~1 |
ISSN | 0145-2126 |
IngestDate | Sat Aug 17 02:53:27 EDT 2024 Thu Sep 12 19:49:56 EDT 2024 Sun Jun 23 00:33:30 EDT 2024 Fri Feb 23 02:41:54 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Long non-coding RNAs, Polymerase Chain reaction Prognosis Chronic myeloid leukemia Imatinib mesylate |
Language | English |
License | Copyright © 2022 Elsevier Ltd. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c295t-b88d6da5d32283e58085ce4e27d8fe16cfc7b920b33b0d52e41da32832caea6e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 35367722 |
PQID | 2646944030 |
PQPubID | 23479 |
PageCount | 1 |
ParticipantIDs | proquest_miscellaneous_2646944030 crossref_primary_10_1016_j_leukres_2022_106838 pubmed_primary_35367722 elsevier_sciencedirect_doi_10_1016_j_leukres_2022_106838 |
PublicationCentury | 2000 |
PublicationDate | May 2022 2022-05-00 20220501 |
PublicationDateYYYYMMDD | 2022-05-01 |
PublicationDate_xml | – month: 05 year: 2022 text: May 2022 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Leukemia research |
PublicationTitleAlternate | Leuk Res |
PublicationYear | 2022 |
Publisher | Elsevier Ltd |
Publisher_xml | – name: Elsevier Ltd |
References | Zhang, He, Zhang, Su, Lu, Si, Chen, Yin, Han, De (bib14) 2018; 19 Cai, Li, Shen, Zhang (bib18) 2018; 51 Necula, Matei, Dragu, Neagu, Mambet, Nedeianu, Bleotu, Diaconu, Chivu-Economescu (bib12) 2019; 25 Chen, Dragomir, Fabris, Bayraktar, Knutsen, Liu, Tang, Li, Shimura, Ivkovic, De Los Santos, Anfossi, Shimizu, Shah, Ling, Shen, Multani, Pardini, Burks, Katayama, Reineke, Huo, Syed, Song, Ferracin, Oki, Fromm, Ivan, Bhuvaneshwar, Gusev, Mimori, Menter, Sen, Matsuyama, Uetake, Vasilescu, Kopetz, Parker-Thornburg, Taguchi, Hanash, Girnita, Slaby, Goel, Varani, Gagea, Li, Ajani, Calin (bib39) 2020; 159 Xu, Yin, Shen, Ju (bib41) 2020; 99 Zhou, Lin, Zhang, Ma, Li, Wen, Guo, Xu, Deng, Zhang, Qian (bib27) 2018; 233 Bavaro, Martelli, Cavo, Soverini (bib1) 2019; 20 Xia, Hui (bib8) 2014; 21 Hochhaus, O'brien, Guilhot, Guilhot, Druker, Branford, Foroni, Goldman, Müller, Radich, Rudoltz, Mone, Gathmann, Hughes, Larson, IRIS, F (bib5) 2009; 23 Bhamidipati, Kantarjian, Cortes, Cornelison, Jabbour (bib29) 2013; 4 Vardiman, Melo, Baccarani (bib23) 2017 Sacha (bib2) 2014; 6 Bixby, Talpaz (bib4) 2009 Loscocco, Visani, Galimberti, Curti, Isidori (bib7) 2019; 9 Huang, Qing, Huang, Zhu (bib22) 2016; 11 Wang, Duan, Yan, Xie, Wang (bib16) 2019; 113 Deininger, Shah, Altman, Berman, Bhatia, Bhatnagar, DeAngelo, Gotlib, Hobbs, Maness, Mead, Metheny, Mohan, Moore, Naqvi, Oehler, Pallera, Patnaik, Pratz, Pusic, Rose, Smith, Snyder, Sweet, Talpaz, Thompson, Yang, Gregory, Sundar (bib24) 2020; 18 Xiao, Jiao, Lin, Chen, Zhang, Wang, Zhang (bib31) 2017; 36 Cai, He, Zhang (bib33) 2015; 8 Li, Zhu, Zhang, Zhang, Zhang (bib40) 2018; 11 Lu, Li, Chai, Kang, Zhao, Xiong, Wang (bib26) 2017; 607 Schmittgen, Livak (bib25) 2008; 3 Ling, Vincent, Pichler, Fodde, Berindan-Neagoe, Slack, Calin (bib28) 2015; 34 Deng, Zhao, Wu, Song (bib21) 2017; 91 Zhao, Wang, Wang, Chang, Zhang, Qu (bib19) 2017; 87 Li, Zhuang, Liu, Chen, Zhou, Chen, He, Zhao, Guo, Wu, Cai, Huang (bib34) 2016; 7 Huang, Liao, Qiu, Li, An (bib20) 2017; 39 Guo, Hu, Yang, Zhang, Kuang, Zhu, Wu (bib36) 2016; 7 Ling, Spizzo, Atlasi, Nicoloso, Shimizu, Redis, Nishida, Gafà, Song, Guo, Ivan, Barbarotto, De Vries, Zhang, Ferracin, Churchman, van Galen, Beverloo, Shariati, Haderk, Estecio, Garcia-Manero, Patijn, Gotley, Bhardwaj, Shureiqi, Sen, Multani, Welsh, Yamamoto, Taniguchi, Song, Gallinger, Casey, Thibodeau, Le Marchand, Tiirikainen, Mani, Zhang, Davuluri, Mimori, Mori, Sieuwerts, Martens, Tomlinson, Negrini, Berindan-Neagoe, Foekens, Hamilton, Lanza, Kopetz, Fodde, Calin (bib15) 2013; 23 Trela, Glowacki, Błasiak (bib3) 2014; 2014 Zheng, Zhao, He, Zheng, Bai, Duan, Cheng, Wang, Liu, Zhang (bib38) 2016; 480 Zhuo, Liu, Li, Guo, Sun, Jin, Rao, Li, Sun, Jiang, Xu, Teng, Jin, Si, Liu, Kang, Zhou (bib13) 2019; 156 Bolha, Ravnik-Glavač, Glavač (bib11) 2017; 2017 Talati, Pinilla-Ibarz (bib6) 2018; 25 Xu, Wang, Zhang, Wang, Du, Hu, Zhu, Fang (bib37) 2017; 10 He, Bai, Kang, Zhang, Jiang (bib30) 2017; 7 Guzel, Okyay, Yalcinkaya, Karacaoglu, Gocmen, Akcakuyu (bib10) 2019; 7 Iyer, Niknafs, Malik, Singhal, Sahu, Hosono, Barrette, Prensner, Evans, Zhao, Poliakov, Cao, Dhanasekaran, Wu, Robinson, Beer, Feng, Iyer, Chinnaiyan (bib9) 2015; 47 Wu, Hao, Qiu, Zhang, Yu, Li (bib17) 2017; 108 Huang, Liao, Qiu, Li, An (bib35) 2017; 39 Zhou, Yuan, Liu, Liu (bib32) 2017; 25 Trela (10.1016/j.leukres.2022.106838_bib3) 2014; 2014 Chen (10.1016/j.leukres.2022.106838_bib39) 2020; 159 Zhao (10.1016/j.leukres.2022.106838_bib19) 2017; 87 Wang (10.1016/j.leukres.2022.106838_bib16) 2019; 113 Bixby (10.1016/j.leukres.2022.106838_bib4) 2009 Huang (10.1016/j.leukres.2022.106838_bib22) 2016; 11 Huang (10.1016/j.leukres.2022.106838_bib35) 2017; 39 Zhuo (10.1016/j.leukres.2022.106838_bib13) 2019; 156 Schmittgen (10.1016/j.leukres.2022.106838_bib25) 2008; 3 Hochhaus (10.1016/j.leukres.2022.106838_bib5) 2009; 23 Talati (10.1016/j.leukres.2022.106838_bib6) 2018; 25 Zhang (10.1016/j.leukres.2022.106838_bib14) 2018; 19 Xu (10.1016/j.leukres.2022.106838_bib41) 2020; 99 Cai (10.1016/j.leukres.2022.106838_bib33) 2015; 8 He (10.1016/j.leukres.2022.106838_bib30) 2017; 7 Li (10.1016/j.leukres.2022.106838_bib40) 2018; 11 Loscocco (10.1016/j.leukres.2022.106838_bib7) 2019; 9 Xia (10.1016/j.leukres.2022.106838_bib8) 2014; 21 Bavaro (10.1016/j.leukres.2022.106838_bib1) 2019; 20 Zhou (10.1016/j.leukres.2022.106838_bib27) 2018; 233 Zhou (10.1016/j.leukres.2022.106838_bib32) 2017; 25 Wu (10.1016/j.leukres.2022.106838_bib17) 2017; 108 Xiao (10.1016/j.leukres.2022.106838_bib31) 2017; 36 Iyer (10.1016/j.leukres.2022.106838_bib9) 2015; 47 Deininger (10.1016/j.leukres.2022.106838_bib24) 2020; 18 Zheng (10.1016/j.leukres.2022.106838_bib38) 2016; 480 Bolha (10.1016/j.leukres.2022.106838_bib11) 2017; 2017 Li (10.1016/j.leukres.2022.106838_bib34) 2016; 7 Necula (10.1016/j.leukres.2022.106838_bib12) 2019; 25 Cai (10.1016/j.leukres.2022.106838_bib18) 2018; 51 Vardiman (10.1016/j.leukres.2022.106838_bib23) 2017 Deng (10.1016/j.leukres.2022.106838_bib21) 2017; 91 Guzel (10.1016/j.leukres.2022.106838_bib10) 2019; 7 Xu (10.1016/j.leukres.2022.106838_bib37) 2017; 10 Huang (10.1016/j.leukres.2022.106838_bib20) 2017; 39 Bhamidipati (10.1016/j.leukres.2022.106838_bib29) 2013; 4 Sacha (10.1016/j.leukres.2022.106838_bib2) 2014; 6 Ling (10.1016/j.leukres.2022.106838_bib15) 2013; 23 Lu (10.1016/j.leukres.2022.106838_bib26) 2017; 607 Ling (10.1016/j.leukres.2022.106838_bib28) 2015; 34 Guo (10.1016/j.leukres.2022.106838_bib36) 2016; 7 |
References_xml | – volume: 6 year: 2014 ident: bib2 article-title: Imatinib in chronic myeloid leukemia: an overview publication-title: Mediterr. J. Hematol. Infect. Dis. contributor: fullname: Sacha – volume: 25 start-page: 2029 year: 2019 end-page: 2044 ident: bib12 article-title: Recent advances in gastric cancer early diagnosis publication-title: World J. Gastroenterol. contributor: fullname: Chivu-Economescu – volume: 25 start-page: 490 year: 2017 end-page: 496 ident: bib32 article-title: LncRNA MEG3 regulates imatinib resistance in chronic myeloid leukemia via suppressing MicroRNA-21 publication-title: Biomol. Ther. (Seoul. ) contributor: fullname: Liu – volume: 233 start-page: 2444 year: 2018 end-page: 2450 ident: bib27 article-title: Hypomethylation-mediated H19 overexpression increases the risk of disease evolution through the association with BCR-ABL transcript in chronic myeloid leukemia publication-title: J. Cell. Physiol. contributor: fullname: Qian – volume: 607 start-page: 41 year: 2017 end-page: 46 ident: bib26 article-title: Long noncoding RNA HULC promotes cell proliferation by regulating PI3K/AKT signaling pathway in chronic myeloid leukemia publication-title: Gene contributor: fullname: Wang – volume: 108 start-page: 317 year: 2017 end-page: 323 ident: bib17 article-title: High expression of long non-coding RNA CCAT2 indicates poor prognosis of gastric cancer and promotes cell proliferation and invasion publication-title: Minerva Med contributor: fullname: Li – volume: 8 start-page: 2657 year: 2015 end-page: 2664 ident: bib33 article-title: Long noncoding RNA CCAT2 promotes breast tumor growth by regulating the Wnt signaling pathway publication-title: Onco Targets Ther. contributor: fullname: Zhang – volume: 39 year: 2017 ident: bib20 article-title: Long non-coding RNA CCAT2 promotes cell proliferation and invasion through regulating Wnt/β-catenin signaling pathway in clear cell renal cell carcinoma publication-title: Tumour Biol. contributor: fullname: An – volume: 36 start-page: 18 year: 2017 end-page: 25 ident: bib31 article-title: lncRNA UCA1 contributes to imatinib resistance by acting as a ceRNA Against miR-16 in chronic myeloid leukemia cells publication-title: DNA Cell Biol. contributor: fullname: Zhang – volume: 21 start-page: 3029 year: 2014 end-page: 3041 ident: bib8 article-title: Mechanism of cancer drug resistance and the involvement of noncoding RNAs publication-title: Curr. Med. Chem. contributor: fullname: Hui – volume: 34 start-page: 5003 year: 2015 end-page: 5011 ident: bib28 article-title: Junk DNA and the long non-coding RNA twist in cancer genetics publication-title: Oncogene contributor: fullname: Calin – volume: 11 start-page: 5658 year: 2018 end-page: 5666 ident: bib40 article-title: Upregulation of lncRNA CCAT2 predicts poor prognosis in patients with acute myeloid leukemia and is correlated with leukemic cell proliferation publication-title: Int J. Clin. Exp. Pathol. contributor: fullname: Zhang – start-page: 30 year: 2017 end-page: 36 ident: bib23 article-title: Chronic myeloid leukaemia BCR-ABL1-positive publication-title: WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues, Revised 4th Edition contributor: fullname: Baccarani – volume: 480 start-page: 508 year: 2016 end-page: 514 ident: bib38 article-title: The up-regulation of long non-coding RNA CCAT2 indicates a poor prognosis for prostate cancer and promotes metastasis by affecting epithelial-mesenchymal transition publication-title: Biochem Biophys. Res Commun. contributor: fullname: Zhang – start-page: 461 year: 2009 end-page: 476 ident: bib4 article-title: Mechanisms of resistance to tyrosine kinase inhibitors in chronic myeloid leukemia and recent therapeutic strategies to overcome resistance publication-title: Hematol. Am. Soc. Hematol. Educ. Program contributor: fullname: Talpaz – volume: 113 year: 2019 ident: bib16 article-title: Circulating long non-coding RNA colon cancer-associated transcript 2 protected by exosome as a potential biomarker for colorectal cancer publication-title: Biomed. Pharm. contributor: fullname: Wang – volume: 7 start-page: 81806 year: 2016 end-page: 81814 ident: bib36 article-title: Knockdown of long non-coding RNA CCAT2 suppressed proliferation and migration of glioma cells publication-title: Oncotarget contributor: fullname: Wu – volume: 51 start-page: 1 year: 2018 ident: bib18 article-title: CCAT2 is an oncogenic long non-coding RNA in pancreatic ductal adenocarcinoma publication-title: Biol. Res. contributor: fullname: Zhang – volume: 7 start-page: 1704 year: 2017 end-page: 1713 ident: bib30 article-title: LncRNA SNHG5 regulates imatinib resistance in chronic myeloid leukemia via acting as a CeRNA against MiR-205-5p publication-title: Am. J. Cancer Res contributor: fullname: Jiang – volume: 23 start-page: 1054 year: 2009 end-page: 1061 ident: bib5 article-title: Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia publication-title: Leukemia contributor: fullname: IRIS, F – volume: 91 start-page: 1160 year: 2017 end-page: 1166 ident: bib21 article-title: Upregulation of CCAT2 promotes cell proliferation by repressing the P15 in breast cancer publication-title: Biomed. Pharm. contributor: fullname: Song – volume: 47 start-page: 199 year: 2015 end-page: 208 ident: bib9 article-title: The landscape of long noncoding RNAs in the human transcriptome publication-title: Nat. Genet contributor: fullname: Chinnaiyan – volume: 7 start-page: 81 year: 2019 end-page: 86 ident: bib10 article-title: Tumor suppressor and oncogenic role of long non-coding RNAs in cancer publication-title: North Clin. Istanb. contributor: fullname: Akcakuyu – volume: 3 start-page: 1101 year: 2008 end-page: 1108 ident: bib25 article-title: Analyzing real-time PCR data by the comparative C(T) method publication-title: Nat. Protoc. contributor: fullname: Livak – volume: 19 start-page: 154 year: 2018 ident: bib14 article-title: A novel long noncoding RNA HOXC-AS3 mediates tumorigenesis of gastric cancer by binding to YBX1 publication-title: Genome Biol. contributor: fullname: De – volume: 18 start-page: 1385 year: 2020 end-page: 1415 ident: bib24 article-title: Chronic myeloid leukemia, version 2.2021, NCCN clinical practice guidelines in oncology publication-title: J. Natl. Compr. Canc Netw. contributor: fullname: Sundar – volume: 7 start-page: 28989 year: 2016 end-page: 28997 ident: bib34 article-title: shRNA targeting long non-coding RNA CCAT2 controlled by tetracycline-inducible system inhibits progression of bladder cancer cells publication-title: Oncotarget contributor: fullname: Huang – volume: 23 start-page: 1446 year: 2013 end-page: 1461 ident: bib15 article-title: CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer publication-title: Genome Res contributor: fullname: Calin – volume: 4 start-page: 103 year: 2013 end-page: 117 ident: bib29 article-title: Management of imatinib-resistant patients with chronic myeloid leukemia publication-title: Ther. Adv. Hematol. contributor: fullname: Jabbour – volume: 39 year: 2017 ident: bib35 article-title: Long non-coding RNA CCAT2 promotes cell proliferation and invasion through regulating Wnt/β-catenin signaling pathway in clear cell renal cell carcinoma publication-title: Tumour Biol. contributor: fullname: An – volume: 25 start-page: 154 year: 2018 end-page: 161 ident: bib6 article-title: Resistance in chronic myeloid leukemia: definitions and novel therapeutic agents publication-title: Curr. Opin. Hematol. contributor: fullname: Pinilla-Ibarz – volume: 10 start-page: 1191 year: 2017 end-page: 1198 ident: bib37 article-title: Long non-coding RNA CCAT2 is associated with poor prognosis in hepatocellular carcinoma and promotes tumor metastasis by regulating Snail2-mediated epithelial–mesenchymal transition publication-title: Onco Targets Ther. contributor: fullname: Fang – volume: 156 start-page: 676 year: 2019 end-page: 691.e11 ident: bib13 article-title: Long Noncoding RNA GMAN, up-regulated in gastric cancer tissues, is associated with metastasis in patients and promotes translation of Ephrin A1 by competitively binding GMAN-AS publication-title: Gastroenterology contributor: fullname: Zhou – volume: 11 start-page: 49 year: 2016 ident: bib22 article-title: The long non-coding RNA CCAT2 is up-regulated in ovarian cancer and associated with poor prognosis publication-title: Diagn. Pathol. contributor: fullname: Zhu – volume: 99 start-page: 2159 year: 2020 end-page: 2171 ident: bib41 article-title: Long non-coding RNA CCAT2 as a potential serum biomarker for diagnosis and prognosis of multiple myeloma publication-title: Ann. Hematol. contributor: fullname: Ju – volume: 2017 year: 2017 ident: bib11 article-title: Long noncoding RNAs as biomarkers in cancer publication-title: Dis. Markers contributor: fullname: Glavač – volume: 87 start-page: 692 year: 2017 end-page: 697 ident: bib19 article-title: LncRNA CCAT2 promotes tumorigenesis by over-expressed Pokemon in non-small cell lung cancer publication-title: Biomed. Pharm. contributor: fullname: Qu – volume: 20 start-page: 6141 year: 2019 ident: bib1 article-title: Mechanisms of disease progression and resistance to tyrosine kinase inhibitor therapy in chronic myeloid leukemia: an update publication-title: Int J. Mol. Sci. contributor: fullname: Soverini – volume: 2014 year: 2014 ident: bib3 article-title: Therapy of chronic myeloid leukemia: twilight of the imatinib era? publication-title: ISRN Oncol. contributor: fullname: Błasiak – volume: 9 start-page: 939 year: 2019 ident: bib7 article-title: BCR-ABL independent mechanisms of resistance in chronic myeloid leukemia publication-title: Front Oncol. contributor: fullname: Isidori – volume: 159 start-page: 2146 year: 2020 end-page: 2162.e33 ident: bib39 article-title: The long noncoding RNA CCAT2 induces chromosomal instability through BOP1-AURKB Signaling publication-title: Gastroenterology contributor: fullname: Calin – volume: 34 start-page: 5003 issue: 39 year: 2015 ident: 10.1016/j.leukres.2022.106838_bib28 article-title: Junk DNA and the long non-coding RNA twist in cancer genetics publication-title: Oncogene doi: 10.1038/onc.2014.456 contributor: fullname: Ling – volume: 480 start-page: 508 issue: 4 year: 2016 ident: 10.1016/j.leukres.2022.106838_bib38 article-title: The up-regulation of long non-coding RNA CCAT2 indicates a poor prognosis for prostate cancer and promotes metastasis by affecting epithelial-mesenchymal transition publication-title: Biochem Biophys. Res Commun. doi: 10.1016/j.bbrc.2016.08.120 contributor: fullname: Zheng – volume: 108 start-page: 317 issue: 4 year: 2017 ident: 10.1016/j.leukres.2022.106838_bib17 article-title: High expression of long non-coding RNA CCAT2 indicates poor prognosis of gastric cancer and promotes cell proliferation and invasion publication-title: Minerva Med doi: 10.23736/S0026-4806.17.04703-6 contributor: fullname: Wu – volume: 39 issue: 7 year: 2017 ident: 10.1016/j.leukres.2022.106838_bib35 article-title: Long non-coding RNA CCAT2 promotes cell proliferation and invasion through regulating Wnt/β-catenin signaling pathway in clear cell renal cell carcinoma publication-title: Tumour Biol. doi: 10.1177/1010428317711314 contributor: fullname: Huang – volume: 20 start-page: 6141 issue: 24 year: 2019 ident: 10.1016/j.leukres.2022.106838_bib1 article-title: Mechanisms of disease progression and resistance to tyrosine kinase inhibitor therapy in chronic myeloid leukemia: an update publication-title: Int J. Mol. Sci. doi: 10.3390/ijms20246141 contributor: fullname: Bavaro – volume: 25 start-page: 2029 issue: 17 year: 2019 ident: 10.1016/j.leukres.2022.106838_bib12 article-title: Recent advances in gastric cancer early diagnosis publication-title: World J. Gastroenterol. doi: 10.3748/wjg.v25.i17.2029 contributor: fullname: Necula – volume: 19 start-page: 154 issue: 1 year: 2018 ident: 10.1016/j.leukres.2022.106838_bib14 article-title: A novel long noncoding RNA HOXC-AS3 mediates tumorigenesis of gastric cancer by binding to YBX1 publication-title: Genome Biol. doi: 10.1186/s13059-018-1523-0 contributor: fullname: Zhang – volume: 25 start-page: 490 issue: 5 year: 2017 ident: 10.1016/j.leukres.2022.106838_bib32 article-title: LncRNA MEG3 regulates imatinib resistance in chronic myeloid leukemia via suppressing MicroRNA-21 publication-title: Biomol. Ther. (Seoul. ) doi: 10.4062/biomolther.2016.162 contributor: fullname: Zhou – volume: 7 start-page: 28989 issue: 20 year: 2016 ident: 10.1016/j.leukres.2022.106838_bib34 article-title: shRNA targeting long non-coding RNA CCAT2 controlled by tetracycline-inducible system inhibits progression of bladder cancer cells publication-title: Oncotarget doi: 10.18632/oncotarget.8259 contributor: fullname: Li – volume: 10 start-page: 1191 year: 2017 ident: 10.1016/j.leukres.2022.106838_bib37 article-title: Long non-coding RNA CCAT2 is associated with poor prognosis in hepatocellular carcinoma and promotes tumor metastasis by regulating Snail2-mediated epithelial–mesenchymal transition publication-title: Onco Targets Ther. doi: 10.2147/OTT.S127100 contributor: fullname: Xu – volume: 11 start-page: 5658 issue: 12 year: 2018 ident: 10.1016/j.leukres.2022.106838_bib40 article-title: Upregulation of lncRNA CCAT2 predicts poor prognosis in patients with acute myeloid leukemia and is correlated with leukemic cell proliferation publication-title: Int J. Clin. Exp. Pathol. contributor: fullname: Li – volume: 47 start-page: 199 issue: 3 year: 2015 ident: 10.1016/j.leukres.2022.106838_bib9 article-title: The landscape of long noncoding RNAs in the human transcriptome publication-title: Nat. Genet doi: 10.1038/ng.3192 contributor: fullname: Iyer – volume: 39 issue: 7 year: 2017 ident: 10.1016/j.leukres.2022.106838_bib20 article-title: Long non-coding RNA CCAT2 promotes cell proliferation and invasion through regulating Wnt/β-catenin signaling pathway in clear cell renal cell carcinoma publication-title: Tumour Biol. doi: 10.1177/1010428317711314 contributor: fullname: Huang – volume: 6 issue: 1 year: 2014 ident: 10.1016/j.leukres.2022.106838_bib2 article-title: Imatinib in chronic myeloid leukemia: an overview publication-title: Mediterr. J. Hematol. Infect. Dis. doi: 10.4084/mjhid.2014.007 contributor: fullname: Sacha – volume: 7 start-page: 81 issue: 1 year: 2019 ident: 10.1016/j.leukres.2022.106838_bib10 article-title: Tumor suppressor and oncogenic role of long non-coding RNAs in cancer publication-title: North Clin. Istanb. contributor: fullname: Guzel – volume: 51 start-page: 1 issue: 1 year: 2018 ident: 10.1016/j.leukres.2022.106838_bib18 article-title: CCAT2 is an oncogenic long non-coding RNA in pancreatic ductal adenocarcinoma publication-title: Biol. Res. doi: 10.1186/s40659-017-0149-0 contributor: fullname: Cai – volume: 36 start-page: 18 issue: 1 year: 2017 ident: 10.1016/j.leukres.2022.106838_bib31 article-title: lncRNA UCA1 contributes to imatinib resistance by acting as a ceRNA Against miR-16 in chronic myeloid leukemia cells publication-title: DNA Cell Biol. doi: 10.1089/dna.2016.3533 contributor: fullname: Xiao – volume: 11 start-page: 49 issue: 1 year: 2016 ident: 10.1016/j.leukres.2022.106838_bib22 article-title: The long non-coding RNA CCAT2 is up-regulated in ovarian cancer and associated with poor prognosis publication-title: Diagn. Pathol. doi: 10.1186/s13000-016-0499-x contributor: fullname: Huang – volume: 9 start-page: 939 year: 2019 ident: 10.1016/j.leukres.2022.106838_bib7 article-title: BCR-ABL independent mechanisms of resistance in chronic myeloid leukemia publication-title: Front Oncol. doi: 10.3389/fonc.2019.00939 contributor: fullname: Loscocco – volume: 99 start-page: 2159 issue: 9 year: 2020 ident: 10.1016/j.leukres.2022.106838_bib41 article-title: Long non-coding RNA CCAT2 as a potential serum biomarker for diagnosis and prognosis of multiple myeloma publication-title: Ann. Hematol. doi: 10.1007/s00277-020-04161-9 contributor: fullname: Xu – start-page: 30 year: 2017 ident: 10.1016/j.leukres.2022.106838_bib23 article-title: Chronic myeloid leukaemia BCR-ABL1-positive contributor: fullname: Vardiman – volume: 607 start-page: 41 year: 2017 ident: 10.1016/j.leukres.2022.106838_bib26 article-title: Long noncoding RNA HULC promotes cell proliferation by regulating PI3K/AKT signaling pathway in chronic myeloid leukemia publication-title: Gene doi: 10.1016/j.gene.2017.01.004 contributor: fullname: Lu – start-page: 461 year: 2009 ident: 10.1016/j.leukres.2022.106838_bib4 article-title: Mechanisms of resistance to tyrosine kinase inhibitors in chronic myeloid leukemia and recent therapeutic strategies to overcome resistance publication-title: Hematol. Am. Soc. Hematol. Educ. Program doi: 10.1182/asheducation-2009.1.461 contributor: fullname: Bixby – volume: 18 start-page: 1385 issue: 10 year: 2020 ident: 10.1016/j.leukres.2022.106838_bib24 article-title: Chronic myeloid leukemia, version 2.2021, NCCN clinical practice guidelines in oncology publication-title: J. Natl. Compr. Canc Netw. doi: 10.6004/jnccn.2020.0047 contributor: fullname: Deininger – volume: 3 start-page: 1101 issue: 6 year: 2008 ident: 10.1016/j.leukres.2022.106838_bib25 article-title: Analyzing real-time PCR data by the comparative C(T) method publication-title: Nat. Protoc. doi: 10.1038/nprot.2008.73 contributor: fullname: Schmittgen – volume: 2017 year: 2017 ident: 10.1016/j.leukres.2022.106838_bib11 article-title: Long noncoding RNAs as biomarkers in cancer publication-title: Dis. Markers doi: 10.1155/2017/7243968 contributor: fullname: Bolha – volume: 7 start-page: 81806 issue: 49 year: 2016 ident: 10.1016/j.leukres.2022.106838_bib36 article-title: Knockdown of long non-coding RNA CCAT2 suppressed proliferation and migration of glioma cells publication-title: Oncotarget doi: 10.18632/oncotarget.13242 contributor: fullname: Guo – volume: 2014 year: 2014 ident: 10.1016/j.leukres.2022.106838_bib3 article-title: Therapy of chronic myeloid leukemia: twilight of the imatinib era? publication-title: ISRN Oncol. contributor: fullname: Trela – volume: 91 start-page: 1160 year: 2017 ident: 10.1016/j.leukres.2022.106838_bib21 article-title: Upregulation of CCAT2 promotes cell proliferation by repressing the P15 in breast cancer publication-title: Biomed. Pharm. doi: 10.1016/j.biopha.2017.05.030 contributor: fullname: Deng – volume: 159 start-page: 2146 issue: 6 year: 2020 ident: 10.1016/j.leukres.2022.106838_bib39 article-title: The long noncoding RNA CCAT2 induces chromosomal instability through BOP1-AURKB Signaling publication-title: Gastroenterology doi: 10.1053/j.gastro.2020.08.018 contributor: fullname: Chen – volume: 21 start-page: 3029 issue: 26 year: 2014 ident: 10.1016/j.leukres.2022.106838_bib8 article-title: Mechanism of cancer drug resistance and the involvement of noncoding RNAs publication-title: Curr. Med. Chem. doi: 10.2174/0929867321666140414101939 contributor: fullname: Xia – volume: 25 start-page: 154 issue: 2 year: 2018 ident: 10.1016/j.leukres.2022.106838_bib6 article-title: Resistance in chronic myeloid leukemia: definitions and novel therapeutic agents publication-title: Curr. Opin. Hematol. doi: 10.1097/MOH.0000000000000403 contributor: fullname: Talati – volume: 113 year: 2019 ident: 10.1016/j.leukres.2022.106838_bib16 article-title: Circulating long non-coding RNA colon cancer-associated transcript 2 protected by exosome as a potential biomarker for colorectal cancer publication-title: Biomed. Pharm. doi: 10.1016/j.biopha.2019.108758 contributor: fullname: Wang – volume: 8 start-page: 2657 year: 2015 ident: 10.1016/j.leukres.2022.106838_bib33 article-title: Long noncoding RNA CCAT2 promotes breast tumor growth by regulating the Wnt signaling pathway publication-title: Onco Targets Ther. contributor: fullname: Cai – volume: 7 start-page: 1704 issue: 8 year: 2017 ident: 10.1016/j.leukres.2022.106838_bib30 article-title: LncRNA SNHG5 regulates imatinib resistance in chronic myeloid leukemia via acting as a CeRNA against MiR-205-5p publication-title: Am. J. Cancer Res contributor: fullname: He – volume: 156 start-page: 676 issue: 3 year: 2019 ident: 10.1016/j.leukres.2022.106838_bib13 article-title: Long Noncoding RNA GMAN, up-regulated in gastric cancer tissues, is associated with metastasis in patients and promotes translation of Ephrin A1 by competitively binding GMAN-AS publication-title: Gastroenterology doi: 10.1053/j.gastro.2018.10.054 contributor: fullname: Zhuo – volume: 23 start-page: 1054 issue: 6 year: 2009 ident: 10.1016/j.leukres.2022.106838_bib5 article-title: Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia publication-title: Leukemia doi: 10.1038/leu.2009.38 contributor: fullname: Hochhaus – volume: 23 start-page: 1446 issue: 9 year: 2013 ident: 10.1016/j.leukres.2022.106838_bib15 article-title: CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer publication-title: Genome Res doi: 10.1101/gr.152942.112 contributor: fullname: Ling – volume: 4 start-page: 103 issue: 2 year: 2013 ident: 10.1016/j.leukres.2022.106838_bib29 article-title: Management of imatinib-resistant patients with chronic myeloid leukemia publication-title: Ther. Adv. Hematol. doi: 10.1177/2040620712468289 contributor: fullname: Bhamidipati – volume: 87 start-page: 692 year: 2017 ident: 10.1016/j.leukres.2022.106838_bib19 article-title: LncRNA CCAT2 promotes tumorigenesis by over-expressed Pokemon in non-small cell lung cancer publication-title: Biomed. Pharm. doi: 10.1016/j.biopha.2016.12.122 contributor: fullname: Zhao – volume: 233 start-page: 2444 issue: 3 year: 2018 ident: 10.1016/j.leukres.2022.106838_bib27 article-title: Hypomethylation-mediated H19 overexpression increases the risk of disease evolution through the association with BCR-ABL transcript in chronic myeloid leukemia publication-title: J. Cell. Physiol. doi: 10.1002/jcp.26119 contributor: fullname: Zhou |
SSID | ssj0005919 |
Score | 2.3991847 |
Snippet | Long noncoding RNAs (lncRNAs) are identified as key players in the initiation, development, and prognosis of chronic myeloid leukemia (CML). Some lncRNAs are... |
SourceID | proquest crossref pubmed elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 106838 |
SubjectTerms | Chronic myeloid leukemia Humans Imatinib mesylate Imatinib Mesylate - therapeutic use Leukemia, Myelogenous, Chronic, BCR-ABL Positive - diagnosis Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics Leukemia, Myeloid, Chronic-Phase - drug therapy Leukemia, Myeloid, Chronic-Phase - genetics Leukocytes, Mononuclear - metabolism Long non-coding RNAs, Polymerase Chain reaction Prognosis RNA, Long Noncoding - genetics |
Title | LncRNA CCAT2 expression at diagnosis predicts imatinib response in chronic phase chronic myeloid leukemia patients |
URI | https://dx.doi.org/10.1016/j.leukres.2022.106838 https://www.ncbi.nlm.nih.gov/pubmed/35367722 https://search.proquest.com/docview/2646944030 |
Volume | 116 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swEBehg7KXsbXrlq0tKuzVSayvyI8hNKRfeSgt9M1I1pW6a52QONC-7G_vyZLbFVYGfdRxwvLd6e6Efnci5JfGsOKcUgmT3CYiHejESsETrQtuFAc0mQblO1PTS3F8Ja86ZNzWwnhYZfT9wac33jpS-lGa_UVZ9j0syReeKtZUmwhfxOcJaNO9P3_BPLLmcQ_PnHjulyqe_m3vDta_8VSLx0TGkKa0L1P5d3x6K_9s4tDkM_kUE0g6Cmv8QjpQbZHNs3hFvk2Wp1VxPhvR8Xh0wSg8RKBrRU1NXcDVlSuKVJxQr2jpM9aqtHQZwLJAy4oWoWMuXdxgjHse3T_C3bx01P8O3JeGxp6sq6_kcnJ4MZ4m8WGFpGCZrBOrtVPOSMd98xuQqDBZgAA2dPoaUlVcF0ObsYHl3A6cZCBSZ7h_1KgwYBTwHbJRzSv4TqiAdAjIay2AcJYhPyhlrR5qk7k07ZJeK858Efpn5C2w7DaP8s-9_PMg_y7RrdDzV4aQo4__39SDVkk5bhJ_82EqmK-RSQmVCYEOrUu-Be09r4ZLrvCIwX68_8M_yUc_CjjIXbJRL9ewh7lKbfcbY9wnH0ZHJ9PZE8O76cQ |
link.rule.ids | 315,786,790,4521,24144,27957,27958,45620,45714 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swED-6FLa9lH0v67ppsFc3sb4sP4awkq5pHkYKfROSdWXuWickDmz__SRLbhlsDPpo-Q5Lp_N9oN-dAD4r71ackzKjgtmM52OVWcFZplTFjGToVaZD-S7k7IJ_vRSXezDta2ECrDLZ_mjTO2udRkZJmqN1XY8CLCkUnkraVZvw8hHsc1HkfAD7k9Oz2eIe6VF293sE-iww3BfyjK6Pb3D3wye2PlOk1I9JFSpV_u6i_hWCdq7o5BkcpBiSTOI0n8MeNi_g8Xk6JX8Jm3lTfVtMyHQ6WVKCPxPWtSGmJS5C6-ot8aOeod2SOgStTW3JJuJlkdQNqWLTXLL-7t3c3dPtL7xZ1Y6E5eBtbUhqy7p9BRcnX5bTWZbuVsgqWoo2s0o56YxwLPS_QeH3TFTIkRZOXWEuq6uqsCUdW8bs2AmKPHeGhXuNKoNGInsNg2bV4FsgHPMCPa21iNxZ6ulRSmtVoUzp8nwIx7049Tq20NA9tuxaJ_nrIH8d5T8E1Qtd_6EL2pv5_7F-6jdJ-_8kHH6YBlc7TyS5LDn3Nm0Ib-Lu3c2GCSZ9lkHfPfzDH-HJbHk-1_PTxdkhPA1vIizyPQzazQ6PfOjS2g9JNX8D073seg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=LncRNA+CCAT2+expression+at+diagnosis+predicts+imatinib+response+in+chronic+phase+chronic+myeloid+leukemia+patients&rft.jtitle=Leukemia+research&rft.au=Shehata%2C+Amira+M.F.&rft.au=Gohar%2C+Suzy+F.&rft.au=Muharram%2C+Nashwa+M.&rft.au=Eldin%2C+Samar+M.+Kamal&rft.date=2022-05-01&rft.pub=Elsevier+Ltd&rft.issn=0145-2126&rft.eissn=1873-5835&rft.volume=116&rft_id=info:doi/10.1016%2Fj.leukres.2022.106838&rft.externalDocID=S0145212622000649 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0145-2126&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0145-2126&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0145-2126&client=summon |